Modifiers of LRRK2 parkinsonism: new therapeutic targets.
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA. Electronic address: ross.owen@mayo.edu.
Owen A
OA
Ross
Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
Rosa
R
Rademakers
D006801:Humans; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 / Q000235:genetics*; D009154:Mutation; D010300:Parkinson Disease; D020734:Parkinsonian Disorders
C495280:LRRK2 protein, human; D000071158:Leucine-Rich Repeat Serine-Threonine Protein Kinase-2